SBRT Clinical Trials
52 recruitingRadiation
Phase 222Not Applicable16Phase 36Phase 15
Showing 1–20 of 52 trials
Recruiting
Not Applicable
Radiotherapy Dose Escalation for Non-operative Management of Unresectable Locally Recurrent Rectal Cancer (STEP-UP)
Locally Recurrent Rectal Cancer
Heike M.U. Peulen30 enrolled5 locationsNCT07721181
Recruiting
Phase 2
Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.
Prostatic Neoplasms, Castration-Resistant
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic51 enrolled15 locationsNCT07717268
Recruiting
Phase 3
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Non-small Cell Lung Cancer
Canadian Cancer Trials Group320 enrolled75 locationsNCT06686771
Recruiting
Phase 2
SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
Ovarian Cancer Recurrent
Institute of Cancer Research, United Kingdom42 enrolled7 locationsNCT05990192
Recruiting
Phase 2
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Genentech, Inc.99 enrolled38 locationsNCT04302025
Recruiting
Not Applicable
OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases
Liver MetastasesStereotactic Body Radiation TherapyMRI-guided Treatment
University of Wisconsin, Madison32 enrolled1 locationNCT04020276
Recruiting
Phase 3
Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)
Stereotactic Body RadiotherapyLocalized Prostate Cancer
University Health Network, Toronto320 enrolled1 locationNCT06825091
Recruiting
Phase 3
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
Stage II-III Non-small Cell Lung Cancer
Shanghai Chest Hospital478 enrolled1 locationNCT06437977
Recruiting
Phase 2
SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Sun Yat-sen University148 enrolled1 locationNCT06323239
Recruiting
Phase 1
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
University of Maryland, Baltimore18 enrolled4 locationsNCT06800339
Recruiting
Not Applicable
Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
RWTH Aachen University30 enrolled1 locationNCT04996914
Recruiting
Not Applicable
Ablative SBRT in Elderly BC Patients
Breast Cancer
University Hospital, Geneva36 enrolled1 locationNCT06523894
Recruiting
Phase 2
SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC
Prostate CancermCRPC (Metastatic Castration-resistant Prostate Cancer)
Fudan University66 enrolled3 locationsNCT07451795
Recruiting
Not Applicable
Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA
Bladder CancerOligometastasisUrothelial Carcinoma (UC)
Istituto Clinico Humanitas44 enrolled1 locationNCT07413523
Recruiting
Phase 2
BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
Non-small Cell Lung Cancer
Brown University25 enrolled1 locationNCT04933903
Recruiting
Phase 3
Efficacy and Safety of SBRT Combined With Becotatug Vedotin (MRG003) in EGFR-Positive Metastatic Tumor Patients With Oligometastases
Oligo-metastatic Cancer
Ming-Yuan Chen200 enrolled2 locationsNCT07481799
Recruiting
Phase 1
Iadademstat + SBRT With Atezo in ES-SCLC
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Yale University15 enrolled1 locationNCT07113691
Recruiting
Phase 2
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
NSCLC (Advanced Non-small Cell Lung Cancer)EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer
Fudan University53 enrolled1 locationNCT06775743
Recruiting
Phase 2
Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer
TNBC - Triple-Negative Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University18 enrolled1 locationNCT07457359
Recruiting
Phase 1
Trial of Oligometastasis SBRT With Immediate, Simulation-Free Treatment Delivery (OLIGO-SWIFT)
Oligometastatic DiseaseOligometastasis
Case Comprehensive Cancer Center15 enrolled1 locationNCT07079098